IL-2-inducible T-cell kinase deficiency: Clinical presentation and therapeutic approach

Haematologica

Volumn 96, Issue 3, 2011, Pages 472-476

  Stepensky, Polina ^a   Weintraub, Michael ^a   Yanir, Asaf ^a   Revel Vilk, Shoshana ^a   Krux, Frank ^b   Huck, Kirsten ^b   Linka, Rene M ^b   Shaag, Avraham ^a   Elpeleg, Orly ^a   Borkhardt, Arndt ^b   Resnick, Igor B ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Bone marrow transplantation; Hereditary childhood EBV positive B cell lymphoma; IL 2 inducible T cell kinase (ITK) deficiency

Indexed keywords

CD20 ANTIGEN; CD30 ANTIGEN; CYCLOSPORIN A; ETOPOSIDE; FLUDARABINE; GEMCITABINE; GENOMIC DNA; INTERLEUKIN 2 INDUCIBLE T CELL KINASE; MELPHALAN; NAVELBINE; PHOSPHOTRANSFERASE; RITUXIMAB; STEROID; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; VALACICLOVIR;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; B CELL LYMPHOMA; CANCER REGRESSION; CASE REPORT; CELL STRAIN HEK293; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME DEFICIENCY; EPSTEIN BARR VIRUS INFECTION; FEMALE; FEVER; FOCAL GLOMERULONEPHRITIS; GENETIC ASSOCIATION; GRAFT VERSUS HOST REACTION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN DEFICIENCY; IMMUNOPHENOTYPING; INTERLEUKIN 2 INDUCIBLE T CELL KINASE DEFICIENCY; KIDNEY BIOPSY; KIDNEY FAILURE; LABORATORY TEST; LINKAGE ANALYSIS; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; MIXED CELLULARITY HODGKIN LYMPHOMA; MULTIPLE ORGAN FAILURE; MUTATIONAL ANALYSIS; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PROTEINURIA; RESPIRATORY FAILURE; SINGLE NUCLEOTIDE POLYMORPHISM; SPLENOMEGALY; STOP CODON; VIRUS DETECTION; VIRUS LOAD;

ANTINEOPLASTIC AGENTS; B-LYMPHOCYTES; BONE MARROW TRANSPLANTATION; CHILD, PRESCHOOL; CODON, NONSENSE; DEATH; DISEASE-FREE SURVIVAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HOMOZYGOTE; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; PEDIGREE; PROTEIN-TYROSINE KINASES; REMISSION INDUCTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 79952335915     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.033910     Document Type: Article

References (25)

1. Schuetz C, Niehues T, Friedrich W, Schwarz K. Autoimmunity, autoinflammation and lymphoma in combined immunodeficiency (CID). Autoimmun Rev. 2010; 9(7):477-82.
2. Tran H, Nourse J, Hall S, Green M, Griffiths L, Gandhi MK. Immunodeficiency-associated lymphomas. Blood Rev. 2008;22(5): 261-81.
3. Shcherbina A, Candotti F, Rosen FS, Remold-O'Donnell E. High incidence of lymphomas in a subgroup of Wiskott- Aldrich syndrome patients. Br J Haematol.2003;121(3):529-30.
4. Okano M, Gross TG. A review of Epstein Barr virus infection in patients with immunodeficiency disorders. Am J Med Sci. 2000;319(6):392-6.
5. Shiloh Y. Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu Rev Genet.1997;31:635-62.
6. Seidemann K, Henze G, Beck JD, Sauerbrey A, Kühl J, Mann G, Reiter A. Non- Hodgkin's lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): experience from the BFM trials. Ann Oncol. 2000;11(Suppl 1):141-5.
7. Filipovich AH, Zhang K, Snow AL, Marsh RA. X-linked lymphoproliferative syndromes: brothers or distant cousins? Blood.2010;116(18):3398-408.
8. Nichols KE, Ma CS, Cannons JL, Schwartzberg PL, Tangye SG. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease Immunol Rev.2005;203:180-99.
9. Gilmour KC, Gaspar HB. Pathogenesis and diagnosis of X-linked lymphoproliferative disease. Expert Rev Mol Diagn. 2003;3(5): 549-61.
10. Rigaud S, Fondanèche MC, Lambert N, Pasquier B, Mateo V, Soulas P, Galicier L, Le Deist F, Rieux-Laucat F, Revy P, Fischer A, de Saint Basile G, Latour S. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 2006;444 (7115):110-4.
11. Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D, van Schaik S, Notarangelo L, Geha R, Roncarolo MG, Oettgen H, De Vries JE, Aversa G, Terhorst C. The Xlinked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature.1998;395(6701):462-9.
12. Huck K, Feyen O, Niehues T, Rüschendorf F, Hübner N, Laws HJ, Telieps T, Knapp S, Wacker HH, Meindl A, Jumaa H, Borkhardt A. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J Clin Invest. 2009; 119(5):1350-8.
13. Pasquier B, Yin L, Fondanèche MC, Relouzat F, Bloch-Queyrat C, Lambert N, Fischer A, de Saint-Basile G, Latour S. Defective NKT cell development in mice and humans lacking the adapter SAP, the Xlinked lymphoproliferative syndrome gene product. J Exp Med. 2005;201(5):695-701.
14. Chung B, Aoukaty A, Dutz J, Terhorst C, Tan R. Signaling lymphocytic activation molecule-associated protein controls NKT cell functions. J Immunol. 2005;174(6): 3153-7.
15. Hildebrandt F, Heeringa SF, Rüschendorf F, Attanasio M, Nürnberg G, Becker C, et al. A systematic approach to mapping recessive disease genes in individuals from outbred populations. PLoS Genet. 2009;5(1): e1000353.
16. Linka RM, Porter ACG, Volkov A, Mielke C, Boege F, Christensen MO. C-terminal regions of topoisomerase iialpha and iibeta determine isoform-specific functioning of the enzymes in vivo. Nucleic Acids Res.2007;35(11):3810-22.
17. Felices M, Berg LJ.The Tec kinases Itk and Rlk regulate NKT cell maturation, cytokine production, and survival. J Immunol. 2008; 180(5):3007-18.
18. Andreotti AH, Schwartzberg PL, Joseph RE, Berg LJ. T-cell signaling regulated by the Tec family kinase, Itk. Cold Spring Harb Perspect Biol. 2010;2(7):a002287.
19. Readinger JA, Mueller KL, Venegas AM, Horai R, Schwartzberg PL. Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk. Immunol Rev. 2009;228(1):93-114.
20. Au-Yeung BB, Fowell DJ. A key role for Itk in both IFN gamma and IL-4 production by NKT cells. J Immunol. 2007;179(1):111-9.
21. Khurana D, Arneson LN, Schoon RA, Dick CJ, Leibson PJ. Differential regulation of human NK cell-mediated cytotoxicity by the tyrosine kinase Itk. J Immunol.2007;178(6):3575-82.
22. Strahm B, Rittweiler K, Duffner U, Brandau O, Orlowska-Volk M, Karajannis MA, Stadt U, Tiemann M, Reiter A, Brandis M, Meindl A, Niemeyer CM. Recurrent B-cell non-Hodgkin's lymphoma in two brothers with X-linked lymphoproliferative disease without evidence for Epstein-Barr virus infection. Br J Haematol. 2000;108(2):377-82.
23. Liang XS, Caporaso N, McMaster ML, Ng D, Landgren O, Yeager M, Chanock S, Goldin LR. Common genetic variants in candidate genes and risk of familial lymphoid malignancies. Br J Haematol. 2009; 146(4):418-23.
24. Brown JR, Neuberg D, Phillips K, Reynolds H, Silverstein J, Clark JC, et al. Prevalence of familial malignancy in a prospectively screened cohort of patients with lymphoproliferative disorders. Br J Haematol.2008;143(3):361-8.
25. Goldin LR, Björkholm M, Kristinsson SY, Turesson I, Landgren O. Highly increased familial risks for specific lymphoma subtypes. Br J Haematol. 2009;146(1):91-4.